Advertisement
Screener

PFIZER INC (PFE) Gain (Loss) Related to Litigation Settlement

PFIZER INC Gain (Loss) Related to Litigation Settlement

PFIZER INC (PFE) reported Gain (Loss) Related to Litigation Settlement of -$842.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossRelatedToLitigationSettlement · last filed 2026-08-04

  • PFIZER INC gain (loss) related to litigation settlement for the quarter ending 2026-06-28 was -$842.00M.
  • PFIZER INC gain (loss) related to litigation settlement for the quarter ending 2026-03-29 was -$191.00M.
  • PFIZER INC gain (loss) related to litigation settlement for the quarter ending 2025-12-31 was -$302.00M.
  • PFIZER INC gain (loss) related to litigation settlement for the quarter ending 2025-09-28 was -$191.00M.
  • PFIZER INC gain (loss) related to litigation settlement for fiscal 2025 was -$1.06B.
  • PFIZER INC gain (loss) related to litigation settlement for fiscal 2024 was -$567.00M.
  • PFIZER INC gain (loss) related to litigation settlement for fiscal 2023 was -$474.00M.
  • PFIZER INC gain (loss) related to litigation settlement for fiscal 2022 was -$230.00M.
Period endGain (Loss) Related to Litigation Settlement 3 monthGain (Loss) Related to Litigation Settlement 3 month as first filedGain (Loss) Related to Litigation Settlement 6 monthGain (Loss) Related to Litigation Settlement 6 month as first filedGain (Loss) Related to Litigation Settlement 9 monthGain (Loss) Related to Litigation Settlement 9 month as first filedGain (Loss) Related to Litigation Settlement 12 monthGain (Loss) Related to Litigation Settlement 12 month as first filed
2026-06-28-$842.00M
10-Q · filed 2026-08-04
-$1.03B
10-Q · filed 2026-08-04
-$1.33B
derived: sum of 3 quarters · filed 2026-08-04
-$1.53B
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29-$191.00M
10-Q · filed 2026-05-05
-$493.00M
derived: sum of 2 quarters · filed 2026-05-05
-$684.00M
derived: sum of 3 quarters · filed 2026-05-05
-$1.11B
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$302.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$493.00M
derived: sum of 2 quarters · filed 2026-02-26
-$915.00M
derived: sum of 3 quarters · filed 2026-08-04
-$1.06B
10-K · filed 2026-02-26
2025-09-28-$191.00M
10-Q · filed 2025-11-04
-$613.00M
derived: sum of 2 quarters · filed 2026-08-04
-$755.00M
10-Q · filed 2025-11-04
-$900.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29-$422.00M
10-Q · filed 2026-08-04
-$564.00M
10-Q · filed 2026-08-04
-$709.00M
derived: sum of 3 quarters · filed 2026-08-04
-$754.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30-$142.00M
10-Q · filed 2026-05-05
-$287.00M
derived: sum of 2 quarters · filed 2026-05-05
-$332.00M
derived: sum of 3 quarters · filed 2026-05-05
-$501.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$145.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$190.00M
derived: sum of 2 quarters · filed 2026-02-26
-$359.00M
derived: sum of 3 quarters · filed 2026-02-26
-$567.00M
10-K · filed 2026-02-26
2024-09-29-$45.00M
10-Q · filed 2025-11-04
-$214.00M
derived: sum of 2 quarters · filed 2025-11-04
-$422.00M
10-Q · filed 2025-11-04
-$650.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$169.00M
10-Q · filed 2025-08-05
-$377.00M
10-Q · filed 2025-08-05
-$605.00M
derived: sum of 3 quarters · filed 2026-02-26
-$676.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$208.00M
10-Q · filed 2025-05-05
-$436.00M
derived: sum of 2 quarters · filed 2026-02-26
-$507.00M
derived: sum of 3 quarters · filed 2026-02-26
-$646.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$228.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$299.00M
derived: sum of 2 quarters · filed 2026-02-26
-$438.00M
derived: sum of 3 quarters · filed 2026-02-26
-$474.00M
10-K · filed 2026-02-26
2023-10-01-$71.00M
10-Q · filed 2024-11-04
-$210.00M
derived: sum of 2 quarters · filed 2024-11-04
-$246.00M
10-Q · filed 2024-11-04
-$301.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02-$139.00M
10-Q · filed 2024-08-05
-$175.00M
10-Q · filed 2024-08-05
-$230.00M
derived: sum of 3 quarters · filed 2025-02-27
-$307.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02-$36.00M
10-Q · filed 2024-05-08
-$91.00M
derived: sum of 2 quarters · filed 2025-02-27
-$168.00M
derived: sum of 3 quarters · filed 2025-02-27
-$187.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$55.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$132.00M
derived: sum of 2 quarters · filed 2025-02-27
-$151.00M
derived: sum of 3 quarters · filed 2025-02-27
-$230.00M
10-K · filed 2025-02-27
2022-10-02-$77.00M
10-Q · filed 2023-11-08
-$96.00M
derived: sum of 2 quarters · filed 2023-11-08
-$175.00M
10-Q · filed 2023-11-08
-$245.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03-$19.00M
10-Q · filed 2023-08-09
-$98.00M
10-Q · filed 2023-08-09
-$168.00M
derived: sum of 3 quarters · filed 2024-02-22
-$206.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03-$79.00M
10-Q · filed 2023-05-10
-$149.00M
derived: sum of 2 quarters · filed 2024-02-22
-$187.00M
derived: sum of 3 quarters · filed 2024-02-22
-$211.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$70.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$108.00M
derived: sum of 2 quarters · filed 2024-02-22
-$132.00M
derived: sum of 3 quarters · filed 2024-02-22
-$182.00M
10-K · filed 2024-02-22
2021-10-03-$38.00M
10-Q · filed 2022-11-09
-$62.00M
derived: sum of 2 quarters · filed 2022-11-09
-$112.00M
10-Q · filed 2022-11-09
-$458.00M
10-Q · filed 2021-11-12
-$136.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04-$24.00M
10-Q · filed 2022-08-10
-$369.00M
10-Q · filed 2021-08-12
-$74.00M
10-Q · filed 2022-08-10
-$420.00M
10-Q · filed 2021-08-12
-$98.00M
derived: sum of 3 quarters · filed 2023-02-23
-$81.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04-$51.00M
10-Q · filed 2022-05-11
-$74.00M
derived: sum of 2 quarters · filed 2023-02-23
-$57.00M
derived: sum of 3 quarters · filed 2023-02-23
-$71.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$23.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$6.00M
derived: sum of 2 quarters · filed 2023-02-23
-$20.00M
derived: sum of 3 quarters · filed 2023-02-23
-$28.00M
10-K · filed 2023-02-23
2020-09-27$17.00M
10-Q · filed 2021-11-12
-$38.00M
10-Q · filed 2020-11-05
$3.00M
derived: sum of 2 quarters · filed 2021-11-12
-$5.00M
10-Q · filed 2021-11-12
-$64.00M
10-Q · filed 2020-11-05
-$214.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28-$14.00M
10-Q · filed 2021-08-12
-$17.00M
10-Q · filed 2020-08-06
-$22.00M
10-Q · filed 2021-08-12
-$26.00M
10-Q · filed 2020-08-06
-$231.00M
derived: sum of 3 quarters · filed 2022-02-24
-$295.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29-$9.00M
10-Q · filed 2021-05-13
-$10.00M
10-Q · filed 2020-05-07
-$217.00M
derived: sum of 2 quarters · filed 2022-02-24
-$281.00M
derived: sum of 3 quarters · filed 2022-02-24
-$296.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$208.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$272.00M
derived: sum of 2 quarters · filed 2022-02-24
-$287.00M
derived: sum of 3 quarters · filed 2022-02-24
-$292.00M
10-K · filed 2022-02-24
-$554.00M
10-K · filed 2020-02-27
2019-09-29-$64.00M
10-Q · filed 2020-11-05
-$79.00M
derived: sum of 2 quarters · filed 2020-11-05
-$84.00M
10-Q · filed 2020-11-05
-$237.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$15.00M
10-Q · filed 2020-08-06
-$19.00M
10-Q · filed 2020-08-06
-$173.00M
derived: sum of 3 quarters · filed 2021-02-25
-$210.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$4.00M
10-Q · filed 2020-05-07
-$158.00M
derived: sum of 2 quarters · filed 2021-02-25
-$195.00M
derived: sum of 3 quarters · filed 2021-02-25
-$107.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$154.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$191.00M
derived: sum of 2 quarters · filed 2021-02-25
-$103.00M
derived: sum of 3 quarters · filed 2021-02-25
-$84.00M
10-K · filed 2021-02-25
-$157.00M
10-K · filed 2019-02-28
2018-09-30-$37.00M
10-Q · filed 2019-11-07
$51.00M
derived: sum of 2 quarters · filed 2019-11-07
$70.00M
10-Q · filed 2019-11-07
$24.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$88.00M
10-Q · filed 2019-08-08
$107.00M
10-Q · filed 2019-08-08
$61.00M
derived: sum of 3 quarters · filed 2020-02-27
-$122.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$19.00M
10-Q · filed 2019-05-09
-$27.00M
derived: sum of 2 quarters · filed 2020-02-27
-$210.00M
derived: sum of 3 quarters · filed 2020-02-27
-$213.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$46.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$229.00M
derived: sum of 2 quarters · filed 2020-02-27
-$232.00M
derived: sum of 3 quarters · filed 2020-02-27
-$240.00M
10-K · filed 2020-02-27
2017-10-01-$183.00M
10-Q · filed 2018-11-08
-$186.00M
derived: sum of 2 quarters · filed 2018-11-08
-$194.00M
10-Q · filed 2018-11-08
-$210.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02-$3.00M
10-Q · filed 2018-08-09
-$11.00M
10-Q · filed 2018-08-09
-$27.00M
derived: sum of 3 quarters · filed 2019-02-28
$13.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02-$8.00M
10-Q · filed 2018-05-10
-$24.00M
derived: sum of 2 quarters · filed 2019-02-28
$16.00M
derived: sum of 3 quarters · filed 2019-02-28
-$245.00M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$24.00M
derived: sum of 2 quarters · filed 2019-02-28
-$237.00M
derived: sum of 3 quarters · filed 2019-02-28
-$510.00M
10-K · filed 2019-02-28
2016-10-02$40.00M
10-Q · filed 2017-11-09
-$221.00M
derived: sum of 2 quarters · filed 2017-11-09
-$494.00M
10-Q · filed 2017-11-09
2016-07-03-$261.00M
10-Q · filed 2017-08-10
-$534.00M
10-Q · filed 2017-08-10
2016-04-03-$274.00M
10-Q · filed 2017-05-11
2015-12-31-$975.00M
10-K · filed 2018-02-22
$0.00
10-K · filed 2016-02-29
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$0.00
derived: sum of 2 quarters · filed 2016-02-29
$0.00
derived: sum of 3 quarters · filed 2016-02-29
$0.00
10-K · filed 2016-02-29
2014-09-28$0.00
10-Q · filed 2014-11-06
$0.00
derived: sum of 2 quarters · filed 2014-11-06
$0.00
10-Q · filed 2014-11-06
2014-06-29$0.00
10-Q · filed 2014-08-07
$0.00
10-Q · filed 2014-08-07
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$9.00M
derived: sum of 2 quarters · filed 2016-02-29
$1.34B
derived: sum of 3 quarters · filed 2016-02-29
$1.34B
10-K · filed 2016-02-29
2013-09-29-$9.00M
10-Q · filed 2014-11-06
$1.34B
derived: sum of 2 quarters · filed 2014-11-06
$1.34B
10-Q · filed 2014-11-06
2013-06-30$1.35B
10-Q · filed 2014-08-07
$1.35B
10-Q · filed 2014-08-07
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$0.00
derived: sum of 2 quarters · filed 2015-02-27
$0.00
derived: sum of 3 quarters · filed 2015-02-27
$0.00
10-K · filed 2015-02-27
2012-09-30$0.00
10-Q · filed 2013-11-08
$0.00
derived: sum of 2 quarters · filed 2013-11-08
$0.00
10-Q · filed 2013-11-08
2012-07-01$0.00
10-Q · filed 2013-08-09
$0.00
10-Q · filed 2013-08-09
2011-12-31$0.00
10-K · filed 2014-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64